NewTimeSpace | International Financial Media Covering Global IPOs, ETFs & Hard-Tech Going Global
  • 简
  • 繁
  • EN
  • 简
  • 繁
  • EN
  • Home
  • Latest
  • Finance
  • IPO
  • ETF
  • Technology
  • Overseas
  • Research
HOME ·

Clinical Trial

HENLIUS(02696.HK): HLX04-O Meets Primary Endpoint in Global Multicenter Phase 3 Trial for Wet Age-Related Macular Degeneration
Tags:
HENLIUS02696.HKClinical Trial
2026-06-16
LongBio Pharma-B(01779.HK): LP-003 Phase III Trial for Seasonal Allergic Rhinitis Hits Primary Endpoint
Tags:
LongBio Pharma-B01779.HKClinical Trial
2026-06-12
UNITED LAB(03933.HK): TUL321 Capsule Granted Implied Approval for Clinical Trials of New Drug in China
Tags:
UNITED LAB03933.HKClinical Trial
2026-06-11
CSPC PHARMA(01093.HK): Phase III Study of Anistolimab Combined with HB1801 for HER2-positive Advanced Breast Cancer Meets Primary Endpoint
Tags:
CSPC PHARMA01093.HKClinical Trial
2026-06-10
HBM HOLDINGS-B (02142.HK): NMPA Accepts IND Application of HBM7004 for Advanced Solid Tumors
Tags:
HBM HOLDINGS-B02142.HKClinical Trial
2026-06-10
Leads Biolabs-B (09887.HK): Core Bispecific Antibody Initiates Phase Ib/II Trial for Triple-Negative Breast Cancer
Tags:
LEADS BIOLABS-B09887.HKClinical Trial
2026-02-10
Previous12 3
Featured News
  • Research
    HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
  • Research
    Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
  • Research
    HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
  • Finance
    Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
  • Finance
    MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
  • Finance
    FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
  • Finance
    SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
  • Finance
    LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
  • Finance
    SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
  • Finance
    HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
新時空
Follow Us:
Follow the official Linkedin account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official Facebook account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official X account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official YouTube account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official Instagram account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology.

Printed By: NewTimeSpace Media Limited

Address: 19H Maxgrand Plaza, No.3 Tai Yau Street, San Po Kong, Kowloon,HK

Email: contact@newtimespace.com

rss RSS API API Subscription App Store App Store
App Store QR Code
Google PlayGoogle Play
Google Play QR Code
huawei AppGalleryAppGallery
Huawei AppGallery QR Code
Company:
  • About NTS
  • Disclaimer
  • Privacy Policy
  • Publishing Principles
  • Brand Materials
  • Contact Us
  • Submission
  • Join Us
NewTimeSpace (newtimespace.com) is registered under Hong Kong Laws, Chapter 268 — the Local Newspapers Ordinance.
Disclaimer: All content on this website/application is the original work of NewTimeSpace. Any reproduction, reprinting, or use of the content of this website/application in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. All information provided on this website/application does not constitute any investment advice. The risks of using this website/application shall be borne by yourself.
Copyright © NewTimeSpace Media Limited All rights reserved. Trademark No. 307068079
  • Download NewTimeSpace App
    Scan QR Code
    Download App